Conjunction of gallium doping and calcium silicate mediates osteoblastic and osteoclastic performances of tricalcium phosphate bioceramics. (10th December 2021)

• Record Type: Journal Article
• Authors: He, Fupo; Qiu, Chao; Lu, Teliang; Shi, Xuetao; Ye, Jiandong
• Is Part Of: Biomedical materials. Volume 17:Number 1(2022)
• Publication Date: 2021-12-10
• Subjects: bone reconstruction -- cell behaviors: calcium phosphate -- calcium silicate -- bioceramics -- element doping; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1088/1748-605X/ac3d9a
• Languages: English
• ISSNs: 1748-6041

Abstract

Abstract: Gallium-containing biomaterials are considered promising for reconstructing osteoporotic bone defects, owing to the potent effect of gallium on restraining osteoclast activities. Nevertheless, the gallium-containing biomaterials were demonstrated to disturb the osteoblast activities. In this study, tricalcium phosphate (TCP) bioceramics were modified by gallium doping in conjunction with incorporation of calcium silicate (CS). The results indicated that the incorporation of CS promoted transition of β -TCP to α -TCP, and accelerated densification process, but did not improve the mechanical strength of bioceramics. The silicon released from the composite bioceramics diminished the inhibition effect of released gallium on osteoblast activities, and maintained its effect on restraining osteoclast activities. The TCP-based bioceramics doped with 2.5 mol% gallium and incorporated with 10 mol% CS are considered suitable for treating the bone defects in the osteoporotic environment.